Modular Medical grants COO 100,000 stock options

One-third of the award vests on October 29, 2027, followed by monthly vesting; the options expire October 29, 2036.

Available on EDGAR 11/09/2026 - 09:57 PM EST Accepted by SEC EDGAR 11/09/2026 - 09:56 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Modular Medical, Inc. (MODD) Chief Operating Officer Kevin Schmid received a direct grant of options to purchase 100,000 common shares on October 29, 2026, at a $1.72 exercise price. The reported post-grant position in this option class was 100,000 options. One-third of the shares subject to the option vests on October 29, 2027, followed by 1/36th monthly thereafter; the options expire October 29, 2036.

Insider Trade Summary

Grant/Award: 100,000 shares

Grant/Award 1 txn

Insider Schmid Kevin

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Option to purchase common stock F1, F2	100,000	$0.00	$0.00

Holdings After Transaction: Option to purchase common stock — 100,000 options (Direct)

Holdings Before and After: Option to purchase common stock, 0 to 100,000 options (Direct)

Footnotes (2)

1. F1. This option shall vest as to 1/3rd of the shares subject to the option on October 29, 2027 and as to 1/36th of the shares subject to the option on a monthly basis thereafter.
2. F2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Key Figures

Option grant: 100,000 options to purchase common shares Exercise price: $1.72 per share Initial vesting: 1/3rd of shares subject to the option +2 more

5 metrics

Option grant 100,000 options to purchase common shares Granted October 29, 2026

Exercise price $1.72 per share Options granted October 29, 2026

Initial vesting 1/3rd of shares subject to the option Vests October 29, 2027

Monthly vesting 1/36th of shares subject to the option Monthly thereafter

Option expiration October 29, 2036 Options granted October 29, 2026

Key Terms

derivative security, beneficial ownership, exercise prices, vesting terms

4 terms

derivative security technical

"class of derivative security reported in Column 1"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

beneficial ownership financial

"total beneficial ownership of the "class" of derivative security"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

exercise prices financial

"different exercise prices or vesting terms"

vesting terms technical

"different exercise prices or vesting terms"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did MODD Chief Operating Officer Kevin Schmid receive, and at what exercise price?

Kevin Schmid received options to purchase 100,000 common shares on October 29, 2026, at a $1.72 exercise price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schmid Kevin

(Last) (First) (Middle)

C/O MODULAR MEDICAL, INC

10740 THORNMINT ROAD

(Street)

SAN DIEGO CALIFORNIA 92127

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Modular Medical, Inc. [ MODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock(1)	$1.72	10/29/2026		A		100,000		(1)	10/29/2036	Common Stock	100,000	$0.00	100,000(2)	D

Explanation of Responses:

1. This option shall vest as to 1/3rd of the shares subject to the option on October 29, 2027 and as to 1/36th of the shares subject to the option on a monthly basis thereafter.

2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

	/s/ James Sullivan, attorney-in-fact for Kevin Schmid	11/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)